Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre L Triozzi

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Melanoma Research|October 31, 2008
Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivoPierre L Triozzi, Wayne Aldrich, Christopher Dombos
Sarcoma|August 31, 2018
Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral ImmunotherapyShailaja Raj, Lance D Miller, Pierre L Triozzi
Cancer Treatment Reviews|January 30, 2008
Targeted therapy for uveal melanomaPierre L Triozzi, Charis Eng, Arun D Singh
Immunotherapy|May 11, 2011
Re-inventing intratumoral immunotherapy for melanomaPierre L Triozzi, Ralph J Tuthill, Ernest Borden
International Ophthalmology Clinics|December 2, 2014
Uveal melanoma: evidence for adjuvant therapyMaria M Choudhary, Pierre L Triozzi, Arun D Singh
Melanoma Research|September 24, 2015
Spontaneous cellular and humoral tumor antigen responses in patients with uveal melanomaPierre L Triozzi, Wayne Aldrich, John W Crabb, et al.
Cancer Immunology, Immunotherapy : CII|February 8, 2012
Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing micePierre L Triozzi, Wayne Aldrich, Susan Achberger, et al.
JACC. Case Reports|October 27, 2022
A First Suspected Case of Fibrosing Mediastinitis After Anti-PD-1 TherapyCarolyn J Park, Sujethra Vasu, Jean L Urbain, et al.
The British Journal of Ophthalmology|August 3, 2019
A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomesElaine Binkley, Pierre L Triozzi, Lisa Rybicki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2012
Differential immunologic and microRNA effects of 2 dosing regimens of recombinant human granulocyte/macrophage colony stimulating factorPierre L Triozzi, Susan Achberger, Wayne Aldrich, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Melanoma Research|October 31, 2008
Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivoPierre L Triozzi, Wayne Aldrich, Christopher Dombos
Sarcoma|August 31, 2018
Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral ImmunotherapyShailaja Raj, Lance D Miller, Pierre L Triozzi
Cancer Treatment Reviews|January 30, 2008
Targeted therapy for uveal melanomaPierre L Triozzi, Charis Eng, Arun D Singh
Immunotherapy|May 11, 2011
Re-inventing intratumoral immunotherapy for melanomaPierre L Triozzi, Ralph J Tuthill, Ernest Borden
International Ophthalmology Clinics|December 2, 2014
Uveal melanoma: evidence for adjuvant therapyMaria M Choudhary, Pierre L Triozzi, Arun D Singh
Melanoma Research|September 24, 2015
Spontaneous cellular and humoral tumor antigen responses in patients with uveal melanomaPierre L Triozzi, Wayne Aldrich, John W Crabb, et al.
Cancer Immunology, Immunotherapy : CII|February 8, 2012
Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing micePierre L Triozzi, Wayne Aldrich, Susan Achberger, et al.
JACC. Case Reports|October 27, 2022
A First Suspected Case of Fibrosing Mediastinitis After Anti-PD-1 TherapyCarolyn J Park, Sujethra Vasu, Jean L Urbain, et al.
The British Journal of Ophthalmology|August 3, 2019
A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomesElaine Binkley, Pierre L Triozzi, Lisa Rybicki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2012
Differential immunologic and microRNA effects of 2 dosing regimens of recombinant human granulocyte/macrophage colony stimulating factorPierre L Triozzi, Susan Achberger, Wayne Aldrich, et al.
Pageof 6